Targeted disruption of the mouse B2 bradykinin receptor in embryonic stem cells.
Two mammalian genes encoding bradykinin (BK) receptors termed B1 and B2 have been identified by molecular cloning techniques. Some pharmacological data suggest the existence of further subtypes of the B2 receptor. To unambiguously determine whether additional genes encoding B2 BK receptors might exist in mammals, steps have been taken toward the generation of mice with a "knockout" of the BK B2 receptor. A genomic clone of the mouse B2 BK receptor was isolated and its coding sequence determined by DNA sequence analysis. A physical map of the DNA flanking this coding sequence was generated. A vector, pBS-KO-1, was constructed for targeted disruption of the mouse B2 receptor gene. This vector contains 1 kb (kilobase) of DNA upstream the mouse B2 receptor coding sequence, a neomycin resistance gene (neo), and 5.4 kb of DNA downstream of the B2 receptor coding sequence. Thus, the correct homologous recombination event will result in a chromosome in which the coding sequence for the mouse B2 BK receptor is replaced with the neomycin resistance gene. pBS-KO-1 was transfected into embryonic stem cells, and clones containing a targeted disruption of the mouse B2 BK receptor were identified.
Borkowski
J A
JA
Department of Molecular Pharmacology and Biochemistry, Merck Research Laboratories, Rahway, NJ 07065, USA.
Hess
J F
JF
D000818:Animals; D001483:Base Sequence; D004622:Embryo, Mammalian / Q000166:cytology; D018390:Gene Targeting; D005822:Genetic Vectors; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D018002:Receptors, Bradykinin / Q000235:genetics*; D013234:Stem Cells / Q000378:metabolism
D018002:Receptors, Bradykinin